Title : Gilteritinib Plus Azacitidine Combination Shows Promise in Newly Diagnosed FLT3-Mutated AML.

Pub. Date : 2021 Feb

PMID : 33368797






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gilteritinib Plus Azacitidine Combination Shows Promise in Newly Diagnosed FLT3-Mutated AML. Azacitidine fms related receptor tyrosine kinase 3 Homo sapiens